semaglutide colitis Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation The weight-loss-independent hepatoprotective benefits of

In rodent models, a number of studies have found that GLP-/GIP dual agonists group mice have reduced fat mass, decreased circulating cholesterol, and lost weight, which has excellent weight loss effect

Although GLP-1R activation lowers blood pressure (BP), the underlying mechanisms remain incompletely understood and have been attributed to weight loss and endothelial cell GLP-1R signaling

How GLP-1 Drugs Cause It: Slowing effect extends beyond the stomach Affects small intestine and colon Food or stool becomes stuck Can be life-threatening without treatment Symptoms: Severe abdominal pain and cramping Inability to pass gas or stool Severe bloating and distention Vomiting (may include fecal material) Loss of appetite Treatment: Often requires emergency hospitalization Nasogastric tube to decompress the stomach IV fluids and electrolytes Some cases require emergency surgery Risk of intestinal perforation or death if untreated Legal Claims: Patients who experienced bowel obstruction or ileus argue: This serious complication was not adequately disclosed Emergency room visits and surgeries could have been prevented Permanent bowel damage occurred Lost wages and medical bills are substantial Learn more about ileus warning signs and symptoms

How long does it take to see results from online medical weight loss programs